Jennifer Buell - 02 May 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Reporting relationship: Director
Issuer ticker: AGEN
Reported as of: 02 May 2025
Net transaction value: +$1,807
SEC form: 4
Accepted by SEC: 06 May 2025, 17:21:12 UTC
Prior SEC filing: 05 May 2025
Next SEC filing: 03 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/Christine M. Klaskin, as Attorney-in-Fact for Jennier Buell

Key filing fact

Jennifer Buell filed Form 4 for AGENUS INC (AGEN) on 06 May 2025.

Key facts

This page summarizes Jennifer Buell's Form 4 filing for AGENUS INC (AGEN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 May 2025, 17:21.

Change

Previous filing in this sequence was filed on 05 May 2025.
Current net transaction value: +$1,807.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001711184 Primary reporting owner

Buell Jennifer

Relationship: Director
Address: C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON
Signature: /s/Christine M. Klaskin, as Attorney-in-Fact for Jennier Buell
Signature date: 06 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGEN transaction

Common Stock

Award

Transaction value: $1,807
Shares: +581
Change %: +3%
Price: $3.11
Shares after: 19,738
Date: 02 May 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

At her request and with the approval of the Agenus Inc. Compensation Committee, a portion of Jennifer Buell's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Buell's salary for the pay period ending May 2, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

Footnote F2

$3.11 is the closing price of our Common Stock on May 2, 2025, the payroll date for the pay period ending May 2, 2025.